A Study of KHK4827 in Patients With Systemic Sclerosis

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT01808482 ·Status: TERMINATED ·Phase: PHASE1

"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

NCT06800404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of GB261 in Systemic Sclerosis

NCT07159009 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

RY_SW01 Cell Injection Therapy in Systemic Sclerosis

NCT06058091 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis

NCT00468611 ·Status: TERMINATED ·Phase: PHASE3

Dose-finding Study of MT-1303

NCT01742052 ·Status: COMPLETED ·Phase: PHASE2

GSK2018682 FTIH in Healthy Volunteers

NCT01387217 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

NCT01431937 ·Status: COMPLETED ·Phase: PHASE1

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis

NCT03972306 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

NCT01006265 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

NCT00207727 ·Status: COMPLETED ·Phase: PHASE2

Seoul National University Hospital Systemic Sclerosis Cohort

NCT02819947 ·Status: UNKNOWN

A Phase IIa Study of NT-KO-003 for Multiple Sclerosis

NCT01428726 ·Status: COMPLETED ·Phase: PHASE2

NOGO-A in Multiple Sclerosis FTIH

NCT01424423 ·Status: TERMINATED ·Phase: PHASE1

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

NCT01435993 ·Status: TERMINATED ·Phase: PHASE1

Study Evaluating CCI-779 in Relapsing Multiple Sclerosis

NCT00228397 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Study of the Effects of SHR1459 in NMOSDs Patients

NCT04670770 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis

NCT05630547 ·Status: TERMINATED ·Phase: PHASE2

Phase II Clinical Trial of OCH-NCNP1

NCT04211740 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers.

NCT01466322 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis

NCT03976648 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis

NCT05265728 ·Status: TERMINATED ·Phase: PHASE3

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

NCT04602390 ·Status: COMPLETED ·Phase: PHASE1

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

NCT02861014 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS

NCT01764737 ·Status: COMPLETED ·Phase: PHASE1